Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase

Documenti analoghi

• Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
  di: Morrow, Linda, et al.
  Pubblicazione: (2013)
• Review of the Mechanism of Action and Clinical Efficacy of Recombinant Human Hyaluronidase Coadministration with Current Prandial Insulin Formulations
  di: Muchmore, Douglas B., et al.
  Pubblicazione: (2010)
• Accelerating and Improving the Consistency of Rapid-Acting Analog Insulin Absorption and Action for Both Subcutaneous Injection and Continuous Subcutaneous Infusion Using Recombinant Human Hyaluronidase
  di: Muchmore, Douglas B., et al.
  Pubblicazione: (2012)
• Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin
  di: Heinemann, Lutz, et al.
  Pubblicazione: (2011)
• Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
  di: Jones, Angus G, et al.
  Pubblicazione: (2012)